Hemostats Market: Growth in the Number of Hospitals & Surgical Centers
The report "Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination,
Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation
(Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", The hemostats market is expected to
reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%.
Growth in this market is driven by the increasing number of surgical procedures, growing number of
regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus
on effective blood loss management in patients during surgeries. In addition, the emerging markets and
growth in the number of hospitals and surgical centers are expected to offer further growth
opportunities for players operating in the hemostats market.
On the other hand, high cost of hemostats and dearth of skilled professionals are expected to hinder the
growth of this market.
Download a PDF Brochure @
The thrombin-based hemostats segment is expected to account for the largest share of the market in
Based on product, the hemostats market is segmented into thrombin-based hemostats, oxidized
regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-
based hemostats. Of all these product segments, the thrombin-based hemostats segment is expected to
account for the largest share of the global hemostats market in 2018.
In 2018, the orthopedic surgery segment is expected to dominate the hemostats market
On the basis of application, the hemostats market is segmented neurological surgery, cardiovascular
surgery, general surgery, orthopedic surgery, gynecological surgery, reconstructive surgery, and other
surgeries. The orthopedic surgery segment is expected to account for the largest share of the hemostats
market in 2018.